MarketsStocksBLISSGVS
BL

Bliss GVS Pharma Ltd

NSE: BLISSGVSBSE: 506197Healthcare
Download Research Report7-page PDF
421.50
-3.84%
NSE · auto-updates while market open
Prev Close
₹136.48
Day High
₹447.50
Day Low
₹417.30
Mkt Cap
₹4,401 Cr
P / E
32.7
P / B
3.7
ROE
12.0%
52W High
₹462.80
52W Low
₹118.00
Key Metrics
Market Cap
₹4,401 Cr
P / E
32.67
P / B
3.69
EV / EBITDA
27.69
ROCE
17.4%
ROE
12.0%
Debt / Equity
0.00
Book Value
₹112.76
EPS
₹12.23
Div Yield
0.2%
Face Value
₹1
Promoter Holding
35.4%
Revenue · ₹ Cr
689
FY20
577
FY21
747
FY22
752
FY23
770
FY24
810
FY25
927
FY26
Net Profit · ₹ Cr
95
FY20
74
FY21
23
FY22
77
FY23
82
FY24
90
FY25
135
FY26
EPS · ₹ per share
₹9.4
FY20
₹6.6
FY21
₹1.5
FY22
₹6.8
FY23
₹7.2
FY24
₹8.0
FY25
₹12.2
FY26
P / E Ratio · price ÷ TTM EPS
02114226331460-1Jun 21Feb 23Oct 24Jun 26
P/E 34.3×Median 16.1×TTM EPS
Q1 2026 snapshot
Sales
₹268 Cr
Operating profit
-
OPM
-
Net profit
₹37 Cr
EPS
₹3.37
Scorecard · 7 axes
Quality
Strong
84/100
Valuation
Avg
32.7×
Growth
Strong
+30.4%
Profitability
Avg
14.7%
Performance
Strong
+214.1%
Entry Point
Weak
91%
Red Flags
Strong
0 flags
Shareholding Pattern
35.4%Promoter
Promoter35.4%
FII10.4%
DII5.0%
Public49.1%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue210.418210.05242.92264.58236.71268.15
Net Profit25.80316.65344.36128.58924.77936.999
NPM %12.3%7.9%18.3%10.8%10.5%13.8%
AlertPre-trade